Bright Minds Biosciences Inc Share Price

NASDAQ: DRUG

Small Cap

$44.43

-1.00

(-2.20%)

as on September 18, 2025 at 1:29 am IST

$₹

Bright Minds Biosciences Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's High
$44.43
Day's Price Range
$46.51
$44.43
4.68%
Upside
52 Week's Low
52 Week's High
$0.94
52-Week Price Range
$79.02
$44.43
97.88%
Downside
77.85%
Upside

Bright Minds Biosciences Inc share price movements today

Previous Close: $45.43
Open: $46.00
Volume: 83.8K
Day's Low - High: $44.43 - $46.51
52 Week Low - High: $0.94 - $79.02

Bright Minds Biosciences Inc Historical Returns

1 Month Return: + 16.36 %
3 Month Return: + 75.73 %
1 Year Return: + 3672.09 %
3 Year Return: + 548.8 %
5 Year Return: 0 %

Bright Minds Biosciences Inc Stock Fundamentals & Key Indicators

Check Bright Minds Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$344.9M

EPS (TTM)

-2.4367

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

786900.00%

Bright Minds Biosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bright Minds Biosciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Bright Minds Biosciences Inc	BUY	$344.9M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Bright Minds Biosciences Inc Stock including INR - Dollar returns

The Bright Minds Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Bright Minds Biosciences Inc investment value today

Current value as on today

₹34,48,784

Returns

₹33,48,784

(+3.35K%)

Returns from Bright Minds Biosciences Inc Stock

₹33,44,186 (+3.34K%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Bright Minds Biosciences Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Bright Minds Biosciences Inc. Average target price of $93.46

Bright Minds Biosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Bright Minds Biosciences Inc.

What analysts predicted

52.46%UPSIDE

Target Price

$93.46

Current Price

$44.43

Analyzed by

7 Analysts

Target

$93.46

Bright Minds Biosciences Inc target price $93.46, a slight upside of 52.46% compared to current price of $44.43. According to 7 analysts rating.

Bright Minds Biosciences Inc Stock's Interest Amongst Investors

Search interest for Bright Minds Biosciences Inc Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-14% versus previous 30 day period

Bright Minds Biosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	-	-	-	-
Operating Income	-1	-1	-1	-1	0	0	0	-1	-3	-3
EBITDA	-2	-1	-1	-1	0	0	0	-1	-3	-3
Interest Expense	0	0	0	0	0	0	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	-1	-1	-1	0	0	0	0	-2	-5
Income Tax Expense	0	0	0	0	0	0	-	-	-	-
Net Income	-1	-1	-1	-1	0	0	0	0	-2	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Bright Minds Biosciences Inc Annual Profit & Loss

All numbers in Millions USD

	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Total Revenue	-	-	-	-	-
Gross Profit	-	-	0	0	-
Operating Income	0	-8	-14	-7	-2
EBITDA	0	-8	-14	-7	-
Interest Expense	-	-	0	0	-
Depreciation	-	-	0	0	0
Income Before Tax	0	-8	-14	-7	-2
Income Tax Expense	0	0	0	0	-
Net Income	0	-6	-11	-5	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Bright Minds Biosciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-1	-1	-1	0	0	0	0	-2	-5
Operating Cash Flow	-1	-1	0	0	0	0	-1	-2	-3
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	0	0	0	0	0	52	0	0
Change in Cash	-1	-1	0	0	0	0	52	-2	-4

Bright Minds Biosciences Inc Annual Cash Flow

All numbers in Millions USD

	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Net Income	0	-8	-14	-7	-2
Operating Cash Flow	0	-7	-13	-7	-1
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	1	26	5	2	0
Change in Cash	0	18	-8	-4	-1

Global Institutional Holdings in Bright Minds Biosciences Inc

Funds	Holdings
HHG PLC	15.69%
Cormorant Asset Management, LLC	14.96%
Sio Capital Management, LLC	7.17%
COMMODORE CAPITAL LP	7.06%
Perceptive Advisors LLC	6.28%

See all

Insights on Bright Minds Biosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 year, DRUG stock has moved up by 3534.4%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, DRUG has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, DRUG has outperformed top 5 stocks with highest market-cap in its industry

About Bright Minds Biosciences Inc

Bright Minds Biosciences Inc. is a biotechnology company. The Company is focused on developing transformative treatments for neuropsychiatric disorders, epilepsy and pain. The Company has a portfolio of serotonin agonists designed to target neurocircuit abnormalities to treat disorders, such as resistant epilepsy, treatment resistant depression, post-traumatic stress disorder (PTSD), and pain. It is focused on developing a line of serotonergic 5-Hydroxytryptamine (5-HT) drug candidates that target the 5-HT2C, 5-HT2A and 5-HT2A + 5-HT2C receptors. Its offers 5-HT2C for the treatment of dravet syndrome and behavioral disorders. Its offers 5-HT2A for treatment of depression and other neuropsychiatric disorders. The Company offers 5-HT2A + 5-HT2C for several chronic pain disorders/neuropathic pain syndromes, including cluster headaches and chemotherapy-induced peripheral neuropathy.

Organisation	Bright Minds Biosciences Inc
Headquarters	19 Vestry Street, New York, NY, United States, 10013
CEO	Mr. Ian McDonald
E-voting on shares	Click here to vote

Key Management of Bright Minds Biosciences Inc

Name	Title
Mr. Ian McDonald	Co-Founder, CEO, President & Director
Dr. Jan Torleif Pedersen M.Sc., Ph.D.	Chief Science Officer & Director
Mr. Alex Vasilkevich	COO & Senior Scientific Officer
Dr. Emer Leahy M.B.A., Ph.D.	Consultant
Dr. Stephen D. Collins M.D., Ph.D.	Chief Medical Officer

FAQs

What is Bright Minds Biosciences Inc share price today?

Bright Minds Biosciences Inc share price today is $44.43 as on September 18, 2025 at 1:29 am IST at the close of the market. Bright Minds Biosciences Inc share today touched a day high of $46.51 and a low of $44.43.

What is the 52 week high and 52 week low for Bright Minds Biosciences Inc share?

Bright Minds Biosciences Inc share touched a 52 week high of $79.02 on October 18, 2024 and a 52 week low of $0.94 on October 9, 2024. Bright Minds Biosciences Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $44.43,which is 43.77% down from its 52 week high and 4626.60% up from its 52 week low.

What is Bright Minds Biosciences Inc's market capitalisation today?

Bright Minds Biosciences Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Bright Minds Biosciences Inc Stock (DRUG) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Bright Minds Biosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bright Minds Biosciences Inc Shares that will get you 0.0338 shares as per Bright Minds Biosciences Inc share price of $44.43 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bright Minds Biosciences Inc Stock (DRUG) from India?

Indian investors can start investing in Bright Minds Biosciences Inc (DRUG) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 10:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Bright Minds Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 10:43 am IST). Based on Bright Minds Biosciences Inc share’s latest price of $44.43 as on September 18, 2025 at 1:29 am IST, you will get 0.2251 shares of Bright Minds Biosciences Inc. Learn more about fractional shares .